| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.0084 | 0.9 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.9 |